NEWS

Venable’s highly-rated Intellectual Property practice adds strength.


New York and Washington (November 1, 2018) – Venable LLP, an American Lawyer Global 100 firm, today announced that Fitzpatrick, Cella, Harper & Scinto, a leading intellectual property firm, has successfully joined Venable effective November 1, 2018. Joining from Fitzpatrick are 97 attorneys and 70 staff members who will be in the New York, Washington, DC, and Los Angeles offices.

With the addition of Fitzpatrick, Venable has approximately 800 attorneys firmwide focused on business, government, intellectual property, and litigation disciplines, and approximately 700 other professionals and staff. The firm’s highly-rated Intellectual Property practice now has about 170 lawyers, making it one of the largest and most sophisticated in the country. In addition, Venable’s New York City presence has grown to more than 160 lawyers, making it one of the largest firms in the city.

Stu Ingis, chairman of Venable, said, “Fitzpatrick has a long-standing reputation as one of the finest IP firms in the country, with an impressive roster of talented attorneys who share our core values and deep commitment to client service. This addition to our existing IP practice will benefit our clients who require deep IP support and strengthen the firm as a whole.”

Dominick Conde, who will serve as co-chair of Venable’s Intellectual Property Division along with Justin Pierce, said, “We are thrilled to officially join Venable, where we can provide our clients with access to an even larger platform and expanded services in business and regulatory law, complex litigation, and legislative affairs. The response from our clients has been extremely positive, and we are excited to roll up our sleeves and begin working together.”

“We are glad to have attorneys from Fitzpatrick join our nationally ranked IP practice and are looking forward to being able to offer new capabilities to clients through this combination,” said Justin Pierce, co-chair of Venable’s Intellectual Property Division.

###

Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, and high-net-worth entrepreneurs and individuals. With more than 700 attorneys across the country, including California, Delaware, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients’ business objectives in the U.S. and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines. For more information, please visit www.Venable.com.


METHODOLOGY

Information contained in the Venable Fitzpatrick BiologicsHQ database relates to FDA-approved drug products listed in the CDER Purple Book or on the FDA website (www.fda.gov). Information relating to FDA licensed products, FDA-approved indications, and aBLA and 505(b)(2) applications is obtained from public sources including the U.S. FDA website (www.fda.gov). Information relating to litigations is given only for cases active from January 31, 2010 onward. Information relating to foreign biosimilar / biologics follow-on products approved in Australia, Canada, the E.U., Japan and South Korea is from public sources. Statistics graphics are compiled from information contained in the Venable Fitzpatrick BiologicsHQ database.

DISCLAIMER

The individuals who maintain this site work for Venable LLP. The information, comments and links posted on this site do not constitute legal advice. No attorney-client relationship has been or will be formed by any communication(s) to, from or with the site and/or the author. For legal advice, contact an attorney at Venable LLP or an attorney actively practicing in your jurisdiction. Do not send any confidential or privileged information to the author; neither Venable LLP nor the author will assume any liability or responsibility for it. If you send any information, documents or materials to the site, you give permission for the author to include them on or in the site. No information, documents or materials you send to the site will be considered confidential or privileged by Venable LLP or its lawyers. Also, no such information, documents or materials will be returned to you. All decisions relating to the content belong to the author.

SUBSCRIBE FOR FUTURE UPDATES

captcha